Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Alexion Pharm Inc (ALXN)

Alexion Pharm Inc (ALXN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 19,937,916
  • Shares Outstanding, K 222,100
  • Annual Sales, $ 4,991 M
  • Annual Income, $ 2,404 M
  • 60-Month Beta 1.37
  • Price/Sales 4.02
  • Price/Cash Flow 7.73
  • Price/Book 1.77

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 2.44
  • Number of Estimates 11
  • High Estimate 2.58
  • Low Estimate 2.30
  • Prior Year 2.19
  • Growth Rate Est. (year over year) +11.42%

Price Performance

See More
Period Period Low Period High Performance
1-Month
72.67 +31.98%
on 03/16/20
96.05 -0.15%
on 04/06/20
+3.93 (+4.27%)
since 03/06/20
3-Month
72.67 +31.98%
on 03/16/20
114.50 -16.24%
on 01/21/20
-10.67 (-10.01%)
since 01/06/20
52-Week
72.67 +31.98%
on 03/16/20
141.86 -32.39%
on 04/10/19
-45.29 (-32.08%)
since 04/05/19

Most Recent Stories

More News
Alexion Pharmaceuticals (ALXN) Gains As Market Dips: What You Should Know

Alexion Pharmaceuticals (ALXN) closed at $89.93 in the latest trading session, marking a +0.16% move from the prior day.

ALXN : 95.91 (+6.84%)
Why Alexion (ALXN) is Poised to Beat Earnings Estimates Again

Alexion (ALXN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

ALXN : 95.91 (+6.84%)
Alexion Pharm Set to Possibly Pullback After Yesterday's Rally of 1.64%

Alexion Pharm (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $85.62 to a high of $89.48. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of...

ALXN : 95.91 (+6.84%)
Alexion Pharmaceuticals (ALXN) Gains But Lags Market: What You Should Know

Alexion Pharmaceuticals (ALXN) closed at $86.14 in the latest trading session, marking a +1.98% move from the prior day.

ALXN : 95.91 (+6.84%)
SmarTrend Watching for Potential Pullback in Shares of Alexion Pharm After 3.81% Gain

Alexion Pharm (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $81.91 to a high of $87.92. Yesterday, the shares gained 3.8%, which took the trading range above the 3-day high of...

ALXN : 95.91 (+6.84%)
Alexion Pharmaceuticals (ALXN) Gains As Market Dips: What You Should Know

Alexion Pharmaceuticals (ALXN) closed the most recent trading day at $82.50, moving +0.17% from the previous trading session.

ALXN : 95.91 (+6.84%)
Alexion Announces Upcoming Data Presentations at 72nd Annual Meeting of the American Academy of Neurology

--- Breadth of data to be presented further support the significant and sustained relapse reduction demonstrated by SOLIRIS in the treatment of adults with NMOSD who are anti-aquaporin-4 (AQP4) antibody-positive...

ALXN : 95.91 (+6.84%)
7.2% Return Seen to Date on SmarTrend Alexion Pharm Call (ALXN)

SmarTrend identified a Downtrend for Alexion Pharm (NASDAQ:ALXN) on January 27th, 2020 at $104.74. In approximately 1 month, Alexion Pharm has returned 7.18% as of today's recent price of $97.22.

ALXN : 95.91 (+6.84%)
Alexion (ALXN) Down 6.3% Since Last Earnings Report: Can It Rebound?

Alexion (ALXN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ALXN : 95.91 (+6.84%)
Alexion Announces Launch of Alexion Charitable Foundation and Calls for Grantees

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the launch of the Alexion Charitable Foundation to provide further support for the rare disease community and for local communities which the...

ALXN : 95.91 (+6.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade ALXN with:

Business Summary

Alexion Pharmaceuticals, Inc. is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the innovation, development and commercialization of life-changing therapies. Alexion is the global leader in complement inhibition and has developed and commercializes...

See More

Key Turning Points

2nd Resistance Point 99.67
1st Resistance Point 97.79
Last Price 95.91
1st Support Level 92.29
2nd Support Level 88.67

See More

52-Week High 141.86
Fibonacci 61.8% 115.43
Fibonacci 50% 107.26
Fibonacci 38.2% 99.10
Last Price 95.91
52-Week Low 72.67

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar